Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Background Pharmaceuticals, while central to medical therapy, pose a significant burden to
health care budgets. Therefore regulations to control prescribing costs and improve quality …

Objective To review international policies to control expenditure on pharmaceuticals by
influencing the behaviour of patients and providers and regulating the pharmaceutical …

Background Growing expenditures on prescription drugs represent a major challenge to
many health systems. Cap and co‐payment (direct cost‐share) policies are intended as an …

Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …

Background Growing expenditures on prescription medicines represent a major challenge
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …

Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …

To contain pharmaceutical spending, drug budgets have been introduced across health
systems. Apart from analyzing whether drug budgets fulfill their overall goal of reducing …

Background Pharmaceuticals can be important for people's health. At the same time drugs
are major components of health care costs. Pharmaceutical pricing and purchasing policies …

European policy makers have increasingly moved from primarily focusing on supply-side
regulation of pharmaceutical costs to offering incentives for providers' prescribing behavior …